C, Y., FZ, Z., EV, C., LLH, L., E, S., JS, W., . . . N, K. (2021). The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study. Dove Medical Press.
Style de citation Chicago (17e éd.)C, Yatawara, Zailan FZ, Chua EV, Lim LLH, Silva E, Wang JS, Ng A, Ng KP, et Kandiah N. The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study. Dove Medical Press, 2021.
Style de citation MLA (8e éd.)C, Yatawara, et al. The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study. Dove Medical Press, 2021.